Analysts Expect More Margin Expansion and Top Line Growth at Vascular (VASC)
Get Alerts VASC Hot Sheet
Price: $56.00 --0%
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Join SI Premium – FREE
Canaccord Genuity reiterated a Buy on Vascular Solutions (NASDAQ: VASC) and raised its price target to $18.75 (from $18.00).
Analyst Jason R. Mills said "We expect VASC to continue to add new products through both internal development and M&A, with which we think it can leverage its 91-person sales force to continue to post double-digit earnings growth and possibly continued upside to EPS expectations."
He also expects solid top-line growth and margin expansion to continue.
For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.
Shares of Vascular Solutions closed at $14.58 yesterday.
Analyst Jason R. Mills said "We expect VASC to continue to add new products through both internal development and M&A, with which we think it can leverage its 91-person sales force to continue to post double-digit earnings growth and possibly continued upside to EPS expectations."
He also expects solid top-line growth and margin expansion to continue.
For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.
Shares of Vascular Solutions closed at $14.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Earnings, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share